Premature ovarian failure

The prevalence of a premature ovarian failure (POF) is about 1 % of all fertile women. The etiology of the disease is heterogenic and in most cases unknown. Patients history and determination of serum FSH (continously above 40 IE/l) is important. Concomitant diseases such as autoimmune diseases or a...

Full description

Saved in:
Bibliographic Details
Main Authors: Runnebaum, Benno (Author) , Rabe, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 01 October 1999
In: Reproduktionsmedizin
Year: 1999, Volume: 15, Issue: 5, Pages: 343-347
ISSN:1434-808X
DOI:10.1007/s004440050124
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s004440050124
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s004440050124
Get full text
Author Notes:B. Runnebaum, T. Rabe
Description
Summary:The prevalence of a premature ovarian failure (POF) is about 1 % of all fertile women. The etiology of the disease is heterogenic and in most cases unknown. Patients history and determination of serum FSH (continously above 40 IE/l) is important. Concomitant diseases such as autoimmune diseases or a galactosemia must be excluded. Fertility cannot be improved by suppression of serum FSH by means of GnRH-analogues or Danazol followed by a high dose stimulation with gonadotropins or a pretreatment with estrogens. The prognosis in view to a pregnancy is unfavourable and in the individual case not predictable. A long term hormone replacement therapy is absolutely required in view to the health of the women with POF. In patients treated with biphasic HRT regimen a spontanous pregnancy cannot be excluded.
Item Description:Es besteht kein Link zum Volltext des Artikels
Gesehen am 01.12.2020
Physical Description:Online Resource
ISSN:1434-808X
DOI:10.1007/s004440050124